First Quadrant’s Meridian Bioscience Inc VIVO Stock Holding History

First Quadrant’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,368	Closed	-$11K	–	861
2020 Q1	$11K	Buy	+1,368	New	+$11.5K	﹤0.01%	621
2018 Q2	–	Sell	-23,808	Closed	-$338K	–	861
2018 Q1	$338K	Buy	23,808 +10,118	+74%	+$150K	0.01%	548
2017 Q4	$192K	Sell	13,690 -1,948	-12%	-$28.5K	﹤0.01%	738
2017 Q3	$224K	Sell	15,638 -947	-6%	-$13.5K	﹤0.01%	690
2017 Q2	$261K	Buy	+16,585	New	+$239K	0.01%	644
2016 Q1	–	Sell	-7,900	Closed	-$162K	–	843
2015 Q4	$162K	Hold	7,900	–	–	﹤0.01%	570
2015 Q3	$135K	Sell	7,900 -7,800	-50%	-$143K	﹤0.01%	584
2015 Q2	$293K	Hold	15,700	–	–	0.01%	526
2015 Q1	$300K	Buy	+15,700	New	+$290K	0.01%	498

Other funds holding VIVO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

First Quadrant's VIVO Position: Q2 2020 in Review

First Quadrant sold out of Meridian Bioscience Inc (VIVO) in Q2 2020, closing a stake of 1,368 shares — an estimated $11K sold.

First Quadrant first reported a position in VIVO in Q1 2015 and held it in 9 quarters. The position peaked at $338K in Q1 2018. 191 funds tracked by Wall St. Rank hold VIVO as of Q2 2020.

First Quadrant reported no remaining Meridian Bioscience Inc position as of Q2 2020 after selling out during the quarter.
First Quadrant sold 1,368 Meridian Bioscience Inc shares in Q2 2020, an estimated $11K.
First Quadrant first reported a position in Meridian Bioscience Inc in Q1 2015 and held it in 9 quarters.
First Quadrant's Meridian Bioscience Inc position peaked at $338K in Q1 2018.
191 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2020.

Based on First Quadrant's 13F filing for Q2 2020, filed 28 Jul 2020.